180-kDa bullous pemphigoid antigen defective generalized atrophic benign epidermolysis bullosa: Report of four cases with an unusually mild phenotype

British Journal of Dermatology

Volumn 138, Issue 5, 1998, Pages 859-866

  Mazzanti, C ^a   Gobello, T ^a   Posteraro, P ^a   Paradisi, M ^a   Meneguzzi, G ^b   Chinni, L ^a   Zambruno, G ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ADULT; AGED; ALOPECIA; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA; EYEBROW; EYELASH; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; KERATINOCYTE; MALE; MOUTH MUCOSA; NAIL DYSTROPHY; PEMPHIGOID; PHENOTYPE; PRIORITY JOURNAL; SCALP; SKIN ATROPHY; WOUND HEALING;

ADULT; AGED; AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEDIGREE; PHENOTYPE; SKIN;

EID: 0031746588     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02226.x     Document Type: Article

References (31)

1. Hashimoto I, Schnyder UW. Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica 1976; 152: 72-86.
2. Schnyder UW, Anton-Lamprecht I. Zur Klinik der Epidermolysen mit junktionaler Blasenbildung. Dermatologica 1979; 159: 402-6.
3. Hinter H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982; 118: 375-84.
4. Paller AS, Fine JD, Kaplan S, Pearson RW. The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States. Arch Dermatol 1986: 122: 704-10.
5. Fine JD, Bauer EA, Briggaman RA et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991; 24: 119-35.
6. Pohla-Gubo G, Lazarova Z. Giudice GJ et al. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol 1995; 4: 199-206.
7. Jonkman MF, De Jong MCJM, Heeres K et al. Generalized atrophic benign epidermolysis bullosa. Either 180-kD bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol 1996; 132: 145-50.
8. Jonkman MF, De Jong MCJM, Heeres K et al. 180-kD bullous pemphigoid antigen (BP1 80) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 1995; 95: 1345-52.
9. McGrath JA, Gatalica B, Christiane AM et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 1995; 11: 83-6.
10. McGrath JA, Pulkkinen L, Christiano AM et al. Altered laminin 5 expression due to mutations in the gene encoding the β3 chain (LAMB 3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1995; 104: 467-74.
11. Jonkman MF, Scheffer H, Stulp R et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997; 88: 543-51.
12. Darling TN, McGrath JA, Yee C et al. Premature termination codons are present on both alleles of bullous pemphigoid antigen 2/type XVII collagen gene in live Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997; 108: 463-8.
13. Gatalica B, Pulkkinen L, Li K et al. Cloning of the human type XVII collagen gene (COL17A1) and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet 1997; 60: 352-65.
14. Kanitakis J, Zambruno G, Viac J et al. Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol 1989; 16: 272-6.
15. Owaribe K, Nishizawa Y, Franke WW. Isolation and characterization of hemidesmosomes from bovine corneal epithelial cells. Exp Cell Res 1991; 192: 622-30.
16. Sonnenberg A, Janssen H, Hogervorst F et al. A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem 1987; 262: 10376-83.
17. Tanaka T, Korman NJ, Shimizu H et al. Production of rabbit antibodies against carboxyterminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol 1990; 94: 617-23.
18. Verrando P, Blanchet-Bardon C, Pisani A et al. Monoclonal antibody GB 3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest 1991; 64: 85-92.
19. Zambruno G, Marchisio PC, Marconi A et al. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αvα6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 1995; 129: 853-65.
20. Chomczynski P, Sacchi N, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
21. Chavanas S, Gache Y, Tadini G et al. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997; 109: 74-8.
22. Baudoin C, Miquel C, Blanchet-Bardon C et al. Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. J Clin Invest 1994; 93: 862-9.
23. Gerecke D, Wagman DW, Champliaud MF et al. The complete primary structure for a novel laminin chain, the laminin B1k chain. J Biol Chem 1994; 269: 11073-80.
24. Vailly J, Verrando P, Champliaud MF et al. The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant, Eur J Biochem 1994; 219: 209-18.
25. Li K, Sawamura D. Giudice GJ et al. Genomic organization of collagenous domains and chromosomal assignment of human 180kD bullous pemphigoid antigen (BPAG2). a novel collagen of stratified squamous epithelium. J Biol Chem 1991; 266: 24064-9.
26. Ishiko A, Shimizu H, Ebihara T et al. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome. whereas those against the 180-kD hullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993; 91: 1608-15.
27. Diaz LA. Ratrie H, Saunders WS et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. J Clin Invest 1990; 86: 1088-94.
28. Balding SD, Prost C, Diaz LA et al. Cicatricial pemphigold autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996; 106: 141-6.
29. Liu Z, Diaz LA. Troy JL et al. A passive transfer model of the organ-specitic autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen. BP180, J Clin Invest 1993; 92: 2480-8.
30. McGrath J. Gatalica B, Li K et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996; 148: 1787-96.
31. McGrath J, Eady RAJ, The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa. J Dermatol Sci 1997; 14: 68-75.